Background Image
Table of Contents Table of Contents
Previous Page  9 / 40 Next Page
Information
Show Menu
Previous Page 9 / 40 Next Page
Page Background

7

Chemical Technology • July 2015

huge immune response. And kill you. So you really do want

the right blood for you.

All-in-all, there are 342 different blood-group antigens, of

which 160 are defined as ‘high prevalence’. If you’re lucky,

you’re in that group and you’ll be able to get a transfusion

in an emergency. If you’re not … let’s just say, you don’t

want to be in that group.

There are, for example, only 43 people in the world with

Rhesus null blood. They have no Rhesus antigens. This

makes their blood heart-breakingly precious since they can

donate to anyone who falls into the rare Rhesus blood type

groups. Donated blood is, literally, a life-saver. And, once

donated, it lasts only 42 days. Given this, and the difficulty

of safely storing and distributing blood to those in need, it

is no surprise that the pharmaceuticals industry has been

looking for suitable alternatives.

Artificial blood

The requirements for any artificial oxygen-carrying blood

are many and various. Firstly, it must be compatible with all

blood-types, ensuring it can be used by anyone. It must be

able to transport oxygen at least as efficiently as does blood;

and that is both in terms of its capacity to absorb oxygen,

and to release it once it gets to its destination. It must last

about 120 days once it is transfused to ensure that its rate

of decay matches your body’s rate of production (otherwise

it’s like having a continuous bleed and requires a just as

continuous top-up). And, if that isn’t enough, it must have

similar properties to blood since your body control systems

are designed to deal with specific homeostatic pressures

and flow-rates.

Blood doesn’t only carry oxygen. It acts to clot at sites

of injury to aid healing. It regulates body temperature and

pH, as well as delivering antibodies and white blood cells

to infection.

There are currently two main approaches to developing

artificial blood. The first is to use haemoglobin (Hb), the

molecule in blood which does the job in the first place.

Given that red blood can only be stored for 42 days, a vast

amount of blood is discarded. One can have a shortage

NANOTECHNOLOGY